ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+4.22%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$290M
AUM Growth
+$290M
(-23%)
Cap. Flow
-$73M
Cap. Flow
% of AUM
-25.2%
Top 10 Holdings %
Top 10 Hldgs %
69.2%
Holding
34
New
2
Increased
3
Reduced
20
Closed
3
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$7.18M |
| 2 |
AXDX
Accelerate Diagnostics
AXDX
|
$2.43M |
| 3 |
Sarepta Therapeutics
SRPT
|
$1.31M |
| 4 |
Fortress Biotech
FBIO
|
$174K |
| 5 |
Iovance Biotherapeutics
IOVA
|
$51.7K |
Top Sells
| 1 |
Acadia Pharmaceuticals
ACAD
|
$19.2M |
| 2 |
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
|
$9.94M |
| 3 |
SRNE
Sorrento Therapeutics, Inc.
SRNE
|
$8.75M |
| 4 |
Vanda Pharmaceuticals
VNDA
|
$8.04M |
| 5 |
SPPI
Spectrum Pharmaceuticals Inc
SPPI
|
$7.87M |
Sector Composition
| 1 | Healthcare | 90.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADYX
26
DELISTED
Adynxx, Inc. Common Stock
ADYX
| $1.8M | 0.62% |
839,100
-10,900
| -1% | -$23.4K |
|
|
CLLS
27
Cellectis
CLLS
$260M
| $1.09M | 0.37% |
35,000
| – | – |
|
28
Gyre Therapeutics
GYRE
$734M
| $224K | 0.08% |
71,500
-12,401
| -15% | -$38.7K |
|
|
29
Acadia Pharmaceuticals
ACAD
$4.34B
| – | – |
-581,900
| Closed | -$19.2M |
|
30
Heron Therapeutics
HRTX
$204M
| – | – |
0
| – | – |
|
31
iShares Russell 2000 ETF
IWM
$66.6B
| – | – |
0
| – | – |
|
|
SCPX
32
DELISTED
Scorpius Holdings, Inc.
SCPX
| – | – |
-341,064
| Closed | -$1.58M |
|
|
SPPI
33
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| – | – |
-1,315,600
| Closed | -$7.87M |
|
|
KITE
34
DELISTED
Kite Pharma, Inc.
KITE
| – | – |
0
| – | – |
|